AC Immune
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $15,113 | $1,119 | $338 | $939 |
Gross Profit | 15,113 | 1,119 | 338 | 939 |
EBITDA | 1,935 | -14,736 | -13,676 | -15,518 |
EBIT | -14,326 | -15,858 | ||
Net Income | 1,874 | -14,801 | -14,373 | -15,858 |
Net Change In Cash | 15,113 | 1,119 | 338 | 939 |
Free Cash Flow | -16,554 | -18,398 | ||
Cash | 27,757 | 19,169 | 26,825 | 27,741 |
Basic Shares | 98,673 | 98,673 | 101,166 | 99,112 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $3,573 | $27,309 | $14,801 | $3,935 |
Gross Profit | 3,573 | -35,261 | -39,805 | 3,935 |
EBITDA | -67,753 | -48,618 | -51,832 | -68,026 |
EBIT | -70,256 | -50,780 | -54,047 | -70,385 |
Net Income | -70,447 | -50,916 | -54,233 | -70,753 |
Net Change In Cash | 3,573 | 27,309 | 14,801 | 3,935 |
Free Cash Flow | -67,007 | 65,266 | -61,209 | -74,807 |
Cash | 26,825 | 36,275 | 78,494 | 31,586 |
Basic Shares | 100,751 | 99,692 | 84,694 | 83,554 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.03 |
2026-03-31 | -$0.15 |
2025-12-31 | -$0.14 |
2025-09-30 | -$0.16 |